nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—MPO—saliva—alcohol dependence	0.0164	0.0808	CbGeAlD
Mesalazine—ALOX5—Eicosanoid Synthesis—GGT2—alcohol dependence	0.00862	0.0858	CbGpPWpGaD
Mesalazine—CHUK—cardiovascular system—alcohol dependence	0.00696	0.0342	CbGeAlD
Mesalazine—CHUK—digestive system—alcohol dependence	0.00577	0.0284	CbGeAlD
Mesalazine—CHUK—blood—alcohol dependence	0.0055	0.027	CbGeAlD
Mesalazine—CHUK—endocrine gland—alcohol dependence	0.00477	0.0235	CbGeAlD
Mesalazine—IKBKB—cardiovascular system—alcohol dependence	0.00473	0.0232	CbGeAlD
Mesalazine—CHUK—testis—alcohol dependence	0.00455	0.0224	CbGeAlD
Mesalazine—ALOX5—Synthesis of Leukotrienes (LT) and Eoxins (EX)—GGT1—alcohol dependence	0.00454	0.0451	CbGpPWpGaD
Mesalazine—CHUK—liver—alcohol dependence	0.0043	0.0211	CbGeAlD
Mesalazine—IKBKB—gonad—alcohol dependence	0.00429	0.0211	CbGeAlD
Mesalazine—CHUK—cerebellum—alcohol dependence	0.0042	0.0207	CbGeAlD
Mesalazine—ALOX5—Eicosanoid Synthesis—GGT1—alcohol dependence	0.00408	0.0406	CbGpPWpGaD
Mesalazine—IKBKB—digestive system—alcohol dependence	0.00392	0.0193	CbGeAlD
Mesalazine—MPO—forebrain—alcohol dependence	0.00392	0.0193	CbGeAlD
Mesalazine—ALOX5—cardiovascular system—alcohol dependence	0.00392	0.0193	CbGeAlD
Mesalazine—ALOX5—pancreas—alcohol dependence	0.00381	0.0187	CbGeAlD
Mesalazine—IKBKB—blood—alcohol dependence	0.00374	0.0184	CbGeAlD
Mesalazine—PTGS1—Eicosanoid Synthesis—GGT2—alcohol dependence	0.00374	0.0372	CbGpPWpGaD
Mesalazine—PPARG—forebrain—alcohol dependence	0.00348	0.0171	CbGeAlD
Mesalazine—CHUK—brain—alcohol dependence	0.00341	0.0168	CbGeAlD
Mesalazine—MPO—cardiovascular system—alcohol dependence	0.00332	0.0163	CbGeAlD
Mesalazine—ALOX5—digestive system—alcohol dependence	0.00325	0.016	CbGeAlD
Mesalazine—IKBKB—endocrine gland—alcohol dependence	0.00324	0.0159	CbGeAlD
Mesalazine—MPO—Selenium Micronutrient Network—GGT2—alcohol dependence	0.00323	0.0321	CbGpPWpGaD
Mesalazine—MPO—pancreas—alcohol dependence	0.00322	0.0158	CbGeAlD
Mesalazine—ALOX5—blood—alcohol dependence	0.0031	0.0152	CbGeAlD
Mesalazine—IKBKB—testis—alcohol dependence	0.00309	0.0152	CbGeAlD
Mesalazine—ALOX5—Selenium Micronutrient Network—GGT2—alcohol dependence	0.00305	0.0303	CbGpPWpGaD
Mesalazine—IKBKB—nervous system—alcohol dependence	0.00304	0.0149	CbGeAlD
Mesalazine—PTGS2—Eicosanoid Synthesis—GGT2—alcohol dependence	0.00297	0.0295	CbGpPWpGaD
Mesalazine—PPARG—cardiovascular system—alcohol dependence	0.00294	0.0145	CbGeAlD
Mesalazine—IKBKB—liver—alcohol dependence	0.00292	0.0144	CbGeAlD
Mesalazine—IKBKB—central nervous system—alcohol dependence	0.00292	0.0144	CbGeAlD
Mesalazine—PPARG—pancreas—alcohol dependence	0.00286	0.0141	CbGeAlD
Mesalazine—IKBKB—cerebellum—alcohol dependence	0.00286	0.014	CbGeAlD
Mesalazine—MPO—digestive system—alcohol dependence	0.00275	0.0135	CbGeAlD
Mesalazine—ALOX5—endocrine gland—alcohol dependence	0.00269	0.0132	CbGeAlD
Mesalazine—MPO—blood—alcohol dependence	0.00262	0.0129	CbGeAlD
Mesalazine—ALOX5—testis—alcohol dependence	0.00256	0.0126	CbGeAlD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00253	0.0252	CbGpPWpGaD
Mesalazine—ALOX5—nervous system—alcohol dependence	0.00252	0.0124	CbGeAlD
Mesalazine—PPARG—digestive system—alcohol dependence	0.00244	0.012	CbGeAlD
Mesalazine—ALOX5—liver—alcohol dependence	0.00242	0.0119	CbGeAlD
Mesalazine—ALOX5—central nervous system—alcohol dependence	0.00242	0.0119	CbGeAlD
Mesalazine—Dopamine—MAOB—alcohol dependence	0.00242	0.168	CrCbGaD
Mesalazine—ALOX5—cerebellum—alcohol dependence	0.00237	0.0116	CbGeAlD
Mesalazine—PPARG—blood—alcohol dependence	0.00233	0.0114	CbGeAlD
Mesalazine—IKBKB—brain—alcohol dependence	0.00232	0.0114	CbGeAlD
Mesalazine—MPO—endocrine gland—alcohol dependence	0.00227	0.0112	CbGeAlD
Mesalazine—ALOX5—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00227	0.0225	CbGpPWpGaD
Mesalazine—MPO—testis—alcohol dependence	0.00217	0.0107	CbGeAlD
Mesalazine—MPO—nervous system—alcohol dependence	0.00213	0.0105	CbGeAlD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.0021	0.0209	CbGpPWpGaD
Mesalazine—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00208	0.0207	CbGpPWpGaD
Mesalazine—MPO—liver—alcohol dependence	0.00205	0.0101	CbGeAlD
Mesalazine—MPO—central nervous system—alcohol dependence	0.00205	0.0101	CbGeAlD
Mesalazine—PPARG—endocrine gland—alcohol dependence	0.00202	0.00992	CbGeAlD
Mesalazine—L-DOPA—DRD4—alcohol dependence	0.00196	0.136	CrCbGaD
Mesalazine—PPARG—testis—alcohol dependence	0.00192	0.00946	CbGeAlD
Mesalazine—ALOX5—brain—alcohol dependence	0.00192	0.00945	CbGeAlD
Mesalazine—PPARG—nervous system—alcohol dependence	0.00189	0.00929	CbGeAlD
Mesalazine—PTGS1—forebrain—alcohol dependence	0.00186	0.00915	CbGeAlD
Mesalazine—Dopamine—DRD4—alcohol dependence	0.00182	0.127	CrCbGaD
Mesalazine—PPARG—liver—alcohol dependence	0.00182	0.00895	CbGeAlD
Mesalazine—PPARG—central nervous system—alcohol dependence	0.00182	0.00894	CbGeAlD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00179	0.0178	CbGpPWpGaD
Mesalazine—PTGS2—forebrain—alcohol dependence	0.00178	0.00874	CbGeAlD
Mesalazine—PTGS1—Eicosanoid Synthesis—GGT1—alcohol dependence	0.00177	0.0176	CbGpPWpGaD
Mesalazine—Dopamine—MAOA—alcohol dependence	0.0017	0.118	CrCbGaD
Mesalazine—Dopamine—HTR7—alcohol dependence	0.00167	0.116	CrCbGaD
Mesalazine—PTGS2—adrenal cortex—alcohol dependence	0.00165	0.0081	CbGeAlD
Mesalazine—MPO—brain—alcohol dependence	0.00163	0.008	CbGeAlD
Mesalazine—PTGS1—cardiovascular system—alcohol dependence	0.00157	0.00773	CbGeAlD
Mesalazine—MPO—Selenium Micronutrient Network—GGT1—alcohol dependence	0.00153	0.0152	CbGpPWpGaD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00152	0.0151	CbGpPWpGaD
Mesalazine—PTGS2—cardiovascular system—alcohol dependence	0.0015	0.00739	CbGeAlD
Mesalazine—Dopamine—SLC6A3—alcohol dependence	0.00146	0.102	CrCbGaD
Mesalazine—PTGS2—pancreas—alcohol dependence	0.00146	0.00718	CbGeAlD
Mesalazine—PPARG—brain—alcohol dependence	0.00144	0.0071	CbGeAlD
Mesalazine—ALOX5—Selenium Micronutrient Network—GGT1—alcohol dependence	0.00144	0.0143	CbGpPWpGaD
Mesalazine—PTGS2—Eicosanoid Synthesis—GGT1—alcohol dependence	0.0014	0.014	CbGpPWpGaD
Mesalazine—PTGS1—Biological oxidations—ADH6—alcohol dependence	0.00135	0.0134	CbGpPWpGaD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00133	0.0132	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—GGT2—alcohol dependence	0.00132	0.0132	CbGpPWpGaD
Mesalazine—PTGS1—digestive system—alcohol dependence	0.00131	0.00642	CbGeAlD
Mesalazine—PTGS2—digestive system—alcohol dependence	0.00125	0.00614	CbGeAlD
Mesalazine—PTGS1—blood—alcohol dependence	0.00124	0.00612	CbGeAlD
Mesalazine—PTGS2—blood—alcohol dependence	0.00119	0.00585	CbGeAlD
Mesalazine—CHUK—TCR Signaling Pathway—OPRM1—alcohol dependence	0.00119	0.0118	CbGpPWpGaD
Mesalazine—PTGS2—midbrain—alcohol dependence	0.00117	0.00577	CbGeAlD
Mesalazine—L-DOPA—DRD2—alcohol dependence	0.00117	0.0813	CrCbGaD
Mesalazine—PTGS1—Biological oxidations—ADH1A—alcohol dependence	0.00112	0.0111	CbGpPWpGaD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.0011	0.011	CbGpPWpGaD
Mesalazine—Dopamine—SLC6A4—alcohol dependence	0.00109	0.076	CrCbGaD
Mesalazine—Dopamine—DRD2—alcohol dependence	0.00109	0.0756	CrCbGaD
Mesalazine—PTGS1—endocrine gland—alcohol dependence	0.00108	0.0053	CbGeAlD
Mesalazine—IKBKB—TCR Signaling Pathway—OPRM1—alcohol dependence	0.00108	0.0107	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—GGT2—alcohol dependence	0.00105	0.0104	CbGpPWpGaD
Mesalazine—PTGS2—endocrine gland—alcohol dependence	0.00103	0.00507	CbGeAlD
Mesalazine—PTGS1—testis—alcohol dependence	0.00103	0.00506	CbGeAlD
Mesalazine—PTGS1—nervous system—alcohol dependence	0.00101	0.00496	CbGeAlD
Mesalazine—PTGS1—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000983	0.00978	CbGpPWpGaD
Mesalazine—PTGS1—central nervous system—alcohol dependence	0.000972	0.00478	CbGeAlD
Mesalazine—PTGS2—nervous system—alcohol dependence	0.000965	0.00475	CbGeAlD
Mesalazine—PTGS1—Biological oxidations—ADH4—alcohol dependence	0.000949	0.00944	CbGpPWpGaD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000938	0.00933	CbGpPWpGaD
Mesalazine—PTGS2—liver—alcohol dependence	0.00093	0.00457	CbGeAlD
Mesalazine—PTGS2—central nervous system—alcohol dependence	0.000929	0.00457	CbGeAlD
Mesalazine—PTGS2—cerebellum—alcohol dependence	0.000908	0.00447	CbGeAlD
Mesalazine—Migraine—Citalopram—alcohol dependence	0.000845	0.00124	CcSEcCtD
Mesalazine—Mediastinal disorder—Naltrexone—alcohol dependence	0.000844	0.00124	CcSEcCtD
Mesalazine—Dysgeusia—Acamprosate—alcohol dependence	0.000844	0.00124	CcSEcCtD
Mesalazine—Chills—Naltrexone—alcohol dependence	0.000841	0.00123	CcSEcCtD
Mesalazine—Nervousness—Acamprosate—alcohol dependence	0.000837	0.00123	CcSEcCtD
Mesalazine—Back pain—Acamprosate—alcohol dependence	0.000834	0.00122	CcSEcCtD
Mesalazine—Muscle spasms—Acamprosate—alcohol dependence	0.000829	0.00122	CcSEcCtD
Mesalazine—Face oedema—Citalopram—alcohol dependence	0.000828	0.00122	CcSEcCtD
Mesalazine—Alopecia—Naltrexone—alcohol dependence	0.000828	0.00121	CcSEcCtD
Mesalazine—Mental disorder—Naltrexone—alcohol dependence	0.000821	0.0012	CcSEcCtD
Mesalazine—Mood swings—Citalopram—alcohol dependence	0.000813	0.00119	CcSEcCtD
Mesalazine—Tremor—Acamprosate—alcohol dependence	0.000808	0.00118	CcSEcCtD
Mesalazine—PTGS1—Biological oxidations—ADH7—alcohol dependence	0.000807	0.00803	CbGpPWpGaD
Mesalazine—Flatulence—Naltrexone—alcohol dependence	0.000804	0.00118	CcSEcCtD
Mesalazine—Tension—Naltrexone—alcohol dependence	0.0008	0.00117	CcSEcCtD
Mesalazine—Ill-defined disorder—Acamprosate—alcohol dependence	0.0008	0.00117	CcSEcCtD
Mesalazine—Dysgeusia—Naltrexone—alcohol dependence	0.000799	0.00117	CcSEcCtD
Mesalazine—Anaemia—Acamprosate—alcohol dependence	0.000797	0.00117	CcSEcCtD
Mesalazine—Liver function test abnormal—Citalopram—alcohol dependence	0.000792	0.00116	CcSEcCtD
Mesalazine—Nervousness—Naltrexone—alcohol dependence	0.000792	0.00116	CcSEcCtD
Mesalazine—Back pain—Naltrexone—alcohol dependence	0.000789	0.00116	CcSEcCtD
Mesalazine—Angioedema—Acamprosate—alcohol dependence	0.000788	0.00116	CcSEcCtD
Mesalazine—Dry skin—Citalopram—alcohol dependence	0.000787	0.00115	CcSEcCtD
Mesalazine—Muscle spasms—Naltrexone—alcohol dependence	0.000784	0.00115	CcSEcCtD
Mesalazine—Abdominal pain upper—Citalopram—alcohol dependence	0.000784	0.00115	CcSEcCtD
Mesalazine—Orthostatic hypotension—Citalopram—alcohol dependence	0.000784	0.00115	CcSEcCtD
Mesalazine—PTGS2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00078	0.00776	CbGpPWpGaD
Mesalazine—Malaise—Acamprosate—alcohol dependence	0.000777	0.00114	CcSEcCtD
Mesalazine—Breast disorder—Citalopram—alcohol dependence	0.000775	0.00114	CcSEcCtD
Mesalazine—Vertigo—Acamprosate—alcohol dependence	0.000774	0.00114	CcSEcCtD
Mesalazine—PTGS1—Biological oxidations—GGT2—alcohol dependence	0.000773	0.00769	CbGpPWpGaD
Mesalazine—Syncope—Acamprosate—alcohol dependence	0.000773	0.00113	CcSEcCtD
Mesalazine—Cramp muscle—Citalopram—alcohol dependence	0.000773	0.00113	CcSEcCtD
Mesalazine—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000773	0.00113	CcSEcCtD
Mesalazine—PTGS1—brain—alcohol dependence	0.000772	0.00379	CbGeAlD
Mesalazine—Leukopenia—Acamprosate—alcohol dependence	0.000772	0.00113	CcSEcCtD
Mesalazine—Vision blurred—Naltrexone—alcohol dependence	0.000769	0.00113	CcSEcCtD
Mesalazine—Nasopharyngitis—Citalopram—alcohol dependence	0.000767	0.00113	CcSEcCtD
Mesalazine—Tremor—Naltrexone—alcohol dependence	0.000764	0.00112	CcSEcCtD
Mesalazine—Palpitations—Acamprosate—alcohol dependence	0.000762	0.00112	CcSEcCtD
Mesalazine—Gastritis—Citalopram—alcohol dependence	0.000759	0.00111	CcSEcCtD
Mesalazine—Loss of consciousness—Acamprosate—alcohol dependence	0.000758	0.00111	CcSEcCtD
Mesalazine—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000757	0.00111	CcSEcCtD
Mesalazine—Ill-defined disorder—Naltrexone—alcohol dependence	0.000757	0.00111	CcSEcCtD
Mesalazine—Cough—Acamprosate—alcohol dependence	0.000752	0.0011	CcSEcCtD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00075	0.00746	CbGpPWpGaD
Mesalazine—Abdominal distension—Citalopram—alcohol dependence	0.000747	0.0011	CcSEcCtD
Mesalazine—Angioedema—Naltrexone—alcohol dependence	0.000745	0.00109	CcSEcCtD
Mesalazine—Hypertension—Acamprosate—alcohol dependence	0.000744	0.00109	CcSEcCtD
Mesalazine—Asthma—Citalopram—alcohol dependence	0.000742	0.00109	CcSEcCtD
Mesalazine—Influenza—Citalopram—alcohol dependence	0.000742	0.00109	CcSEcCtD
Mesalazine—Dysphagia—Citalopram—alcohol dependence	0.000742	0.00109	CcSEcCtD
Mesalazine—PTGS2—brain—alcohol dependence	0.000738	0.00363	CbGeAlD
Mesalazine—Malaise—Naltrexone—alcohol dependence	0.000735	0.00108	CcSEcCtD
Mesalazine—Eosinophilia—Citalopram—alcohol dependence	0.000734	0.00108	CcSEcCtD
Mesalazine—Chest pain—Acamprosate—alcohol dependence	0.000734	0.00108	CcSEcCtD
Mesalazine—Arthralgia—Acamprosate—alcohol dependence	0.000734	0.00108	CcSEcCtD
Mesalazine—Myalgia—Acamprosate—alcohol dependence	0.000734	0.00108	CcSEcCtD
Mesalazine—Syncope—Naltrexone—alcohol dependence	0.000731	0.00107	CcSEcCtD
Mesalazine—Anxiety—Acamprosate—alcohol dependence	0.000731	0.00107	CcSEcCtD
Mesalazine—Bronchospasm—Citalopram—alcohol dependence	0.00073	0.00107	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000729	0.00107	CcSEcCtD
Mesalazine—Pancreatitis—Citalopram—alcohol dependence	0.000727	0.00107	CcSEcCtD
Mesalazine—Discomfort—Acamprosate—alcohol dependence	0.000725	0.00106	CcSEcCtD
Mesalazine—Angina pectoris—Citalopram—alcohol dependence	0.000722	0.00106	CcSEcCtD
Mesalazine—Palpitations—Naltrexone—alcohol dependence	0.000721	0.00106	CcSEcCtD
Mesalazine—Dry mouth—Acamprosate—alcohol dependence	0.000718	0.00105	CcSEcCtD
Mesalazine—Loss of consciousness—Naltrexone—alcohol dependence	0.000717	0.00105	CcSEcCtD
Mesalazine—Bronchitis—Citalopram—alcohol dependence	0.000713	0.00105	CcSEcCtD
Mesalazine—Cough—Naltrexone—alcohol dependence	0.000712	0.00104	CcSEcCtD
Mesalazine—Abdominal discomfort—Citalopram—alcohol dependence	0.000711	0.00104	CcSEcCtD
Mesalazine—Confusional state—Acamprosate—alcohol dependence	0.000709	0.00104	CcSEcCtD
Mesalazine—PTGS1—Biological oxidations—ADH1B—alcohol dependence	0.000707	0.00704	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—PDYN—alcohol dependence	0.000706	0.00702	CbGpPWpGaD
Mesalazine—Pancytopenia—Citalopram—alcohol dependence	0.000704	0.00103	CcSEcCtD
Mesalazine—Hypertension—Naltrexone—alcohol dependence	0.000704	0.00103	CcSEcCtD
Mesalazine—Anaphylactic shock—Acamprosate—alcohol dependence	0.000704	0.00103	CcSEcCtD
Mesalazine—Infection—Acamprosate—alcohol dependence	0.000699	0.00103	CcSEcCtD
Mesalazine—Chest pain—Naltrexone—alcohol dependence	0.000694	0.00102	CcSEcCtD
Mesalazine—Arthralgia—Naltrexone—alcohol dependence	0.000694	0.00102	CcSEcCtD
Mesalazine—Myalgia—Naltrexone—alcohol dependence	0.000694	0.00102	CcSEcCtD
Mesalazine—Dysuria—Citalopram—alcohol dependence	0.000694	0.00102	CcSEcCtD
Mesalazine—Shock—Acamprosate—alcohol dependence	0.000692	0.00102	CcSEcCtD
Mesalazine—Anxiety—Naltrexone—alcohol dependence	0.000692	0.00102	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00069	0.00101	CcSEcCtD
Mesalazine—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000689	0.00101	CcSEcCtD
Mesalazine—Thrombocytopenia—Acamprosate—alcohol dependence	0.000689	0.00101	CcSEcCtD
Mesalazine—Tachycardia—Acamprosate—alcohol dependence	0.000687	0.00101	CcSEcCtD
Mesalazine—Discomfort—Naltrexone—alcohol dependence	0.000686	0.00101	CcSEcCtD
Mesalazine—Pollakiuria—Citalopram—alcohol dependence	0.000685	0.00101	CcSEcCtD
Mesalazine—Skin disorder—Acamprosate—alcohol dependence	0.000683	0.001	CcSEcCtD
Mesalazine—Hyperhidrosis—Acamprosate—alcohol dependence	0.00068	0.000998	CcSEcCtD
Mesalazine—Dry mouth—Naltrexone—alcohol dependence	0.000679	0.000996	CcSEcCtD
Mesalazine—Photosensitivity reaction—Citalopram—alcohol dependence	0.000677	0.000993	CcSEcCtD
Mesalazine—Weight increased—Citalopram—alcohol dependence	0.000675	0.00099	CcSEcCtD
Mesalazine—Confusional state—Naltrexone—alcohol dependence	0.000671	0.000985	CcSEcCtD
Mesalazine—Weight decreased—Citalopram—alcohol dependence	0.000671	0.000984	CcSEcCtD
Mesalazine—Anorexia—Acamprosate—alcohol dependence	0.000671	0.000984	CcSEcCtD
Mesalazine—Oedema—Naltrexone—alcohol dependence	0.000666	0.000976	CcSEcCtD
Mesalazine—Anaphylactic shock—Naltrexone—alcohol dependence	0.000666	0.000976	CcSEcCtD
Mesalazine—Pneumonia—Citalopram—alcohol dependence	0.000665	0.000976	CcSEcCtD
Mesalazine—Infection—Naltrexone—alcohol dependence	0.000661	0.00097	CcSEcCtD
Mesalazine—Infestation NOS—Citalopram—alcohol dependence	0.000661	0.00097	CcSEcCtD
Mesalazine—Infestation—Citalopram—alcohol dependence	0.000661	0.00097	CcSEcCtD
Mesalazine—Depression—Citalopram—alcohol dependence	0.000659	0.000967	CcSEcCtD
Mesalazine—Hypotension—Acamprosate—alcohol dependence	0.000657	0.000964	CcSEcCtD
Mesalazine—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000656	0.000962	CcSEcCtD
Mesalazine—Shock—Naltrexone—alcohol dependence	0.000655	0.000961	CcSEcCtD
Mesalazine—Nervous system disorder—Naltrexone—alcohol dependence	0.000653	0.000958	CcSEcCtD
Mesalazine—Tachycardia—Naltrexone—alcohol dependence	0.00065	0.000953	CcSEcCtD
Mesalazine—Neuropathy peripheral—Citalopram—alcohol dependence	0.000648	0.000951	CcSEcCtD
Mesalazine—Skin disorder—Naltrexone—alcohol dependence	0.000647	0.000948	CcSEcCtD
Mesalazine—Jaundice—Citalopram—alcohol dependence	0.000645	0.000946	CcSEcCtD
Mesalazine—Stomatitis—Citalopram—alcohol dependence	0.000645	0.000946	CcSEcCtD
Mesalazine—Hyperhidrosis—Naltrexone—alcohol dependence	0.000643	0.000944	CcSEcCtD
Mesalazine—Conjunctivitis—Citalopram—alcohol dependence	0.000643	0.000943	CcSEcCtD
Mesalazine—Urinary tract infection—Citalopram—alcohol dependence	0.000643	0.000943	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000641	0.00094	CcSEcCtD
Mesalazine—Insomnia—Acamprosate—alcohol dependence	0.000636	0.000933	CcSEcCtD
Mesalazine—Anorexia—Naltrexone—alcohol dependence	0.000634	0.000931	CcSEcCtD
Mesalazine—Sweating—Citalopram—alcohol dependence	0.000634	0.00093	CcSEcCtD
Mesalazine—Paraesthesia—Acamprosate—alcohol dependence	0.000632	0.000927	CcSEcCtD
Mesalazine—Haematuria—Citalopram—alcohol dependence	0.000631	0.000925	CcSEcCtD
Mesalazine—Dyspnoea—Acamprosate—alcohol dependence	0.000627	0.00092	CcSEcCtD
Mesalazine—Somnolence—Acamprosate—alcohol dependence	0.000625	0.000917	CcSEcCtD
Mesalazine—Hepatobiliary disease—Citalopram—alcohol dependence	0.000625	0.000917	CcSEcCtD
Mesalazine—PTGS1—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000625	0.00622	CbGpPWpGaD
Mesalazine—Epistaxis—Citalopram—alcohol dependence	0.000624	0.000915	CcSEcCtD
Mesalazine—Sinusitis—Citalopram—alcohol dependence	0.00062	0.00091	CcSEcCtD
Mesalazine—Dyspepsia—Acamprosate—alcohol dependence	0.000619	0.000908	CcSEcCtD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000617	0.00614	CbGpPWpGaD
Mesalazine—Agranulocytosis—Citalopram—alcohol dependence	0.000617	0.000905	CcSEcCtD
Mesalazine—MPO—C-MYB transcription factor network—EP300—alcohol dependence	0.000614	0.00611	CbGpPWpGaD
Mesalazine—Decreased appetite—Acamprosate—alcohol dependence	0.000612	0.000897	CcSEcCtD
Mesalazine—CHUK—BDNF signaling pathway—GRIN2B—alcohol dependence	0.000609	0.00605	CbGpPWpGaD
Mesalazine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000607	0.000891	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000606	0.00089	CcSEcCtD
Mesalazine—CHUK—BDNF signaling pathway—CNR1—alcohol dependence	0.000604	0.00601	CbGpPWpGaD
Mesalazine—Insomnia—Naltrexone—alcohol dependence	0.000602	0.000883	CcSEcCtD
Mesalazine—Pain—Acamprosate—alcohol dependence	0.000602	0.000883	CcSEcCtD
Mesalazine—Constipation—Acamprosate—alcohol dependence	0.000602	0.000883	CcSEcCtD
Mesalazine—Paraesthesia—Naltrexone—alcohol dependence	0.000598	0.000877	CcSEcCtD
Mesalazine—Haemoglobin—Citalopram—alcohol dependence	0.000597	0.000875	CcSEcCtD
Mesalazine—Rhinitis—Citalopram—alcohol dependence	0.000595	0.000873	CcSEcCtD
Mesalazine—Hepatitis—Citalopram—alcohol dependence	0.000594	0.000871	CcSEcCtD
Mesalazine—Haemorrhage—Citalopram—alcohol dependence	0.000594	0.000871	CcSEcCtD
Mesalazine—Dyspnoea—Naltrexone—alcohol dependence	0.000593	0.000871	CcSEcCtD
Mesalazine—Somnolence—Naltrexone—alcohol dependence	0.000592	0.000868	CcSEcCtD
Mesalazine—PPARG—Circadian rythm related genes—CRH—alcohol dependence	0.000591	0.00587	CbGpPWpGaD
Mesalazine—Pharyngitis—Citalopram—alcohol dependence	0.000589	0.000864	CcSEcCtD
Mesalazine—Urinary tract disorder—Citalopram—alcohol dependence	0.000586	0.00086	CcSEcCtD
Mesalazine—PTGS1—Biological oxidations—MAOB—alcohol dependence	0.000586	0.00583	CbGpPWpGaD
Mesalazine—Oedema peripheral—Citalopram—alcohol dependence	0.000585	0.000858	CcSEcCtD
Mesalazine—Connective tissue disorder—Citalopram—alcohol dependence	0.000583	0.000856	CcSEcCtD
Mesalazine—Urethral disorder—Citalopram—alcohol dependence	0.000582	0.000854	CcSEcCtD
Mesalazine—Feeling abnormal—Acamprosate—alcohol dependence	0.00058	0.00085	CcSEcCtD
Mesalazine—Decreased appetite—Naltrexone—alcohol dependence	0.000579	0.000849	CcSEcCtD
Mesalazine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000575	0.000844	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000575	0.000843	CcSEcCtD
Mesalazine—Fatigue—Naltrexone—alcohol dependence	0.000574	0.000842	CcSEcCtD
Mesalazine—Pain—Naltrexone—alcohol dependence	0.000569	0.000835	CcSEcCtD
Mesalazine—Constipation—Naltrexone—alcohol dependence	0.000569	0.000835	CcSEcCtD
Mesalazine—Erythema multiforme—Citalopram—alcohol dependence	0.000561	0.000823	CcSEcCtD
Mesalazine—Urticaria—Acamprosate—alcohol dependence	0.000559	0.00082	CcSEcCtD
Mesalazine—Abdominal pain—Acamprosate—alcohol dependence	0.000556	0.000816	CcSEcCtD
Mesalazine—Body temperature increased—Acamprosate—alcohol dependence	0.000556	0.000816	CcSEcCtD
Mesalazine—Eye disorder—Citalopram—alcohol dependence	0.000555	0.000814	CcSEcCtD
Mesalazine—Tinnitus—Citalopram—alcohol dependence	0.000553	0.000812	CcSEcCtD
Mesalazine—IKBKB—BDNF signaling pathway—GRIN2B—alcohol dependence	0.000552	0.00549	CbGpPWpGaD
Mesalazine—Cardiac disorder—Citalopram—alcohol dependence	0.000551	0.000808	CcSEcCtD
Mesalazine—PPARG—Circadian rythm related genes—SLC6A4—alcohol dependence	0.000549	0.00546	CbGpPWpGaD
Mesalazine—Feeling abnormal—Naltrexone—alcohol dependence	0.000549	0.000805	CcSEcCtD
Mesalazine—IKBKB—BDNF signaling pathway—CNR1—alcohol dependence	0.000548	0.00545	CbGpPWpGaD
Mesalazine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000544	0.000798	CcSEcCtD
Mesalazine—Angiopathy—Citalopram—alcohol dependence	0.000539	0.00079	CcSEcCtD
Mesalazine—Immune system disorder—Citalopram—alcohol dependence	0.000536	0.000787	CcSEcCtD
Mesalazine—Mediastinal disorder—Citalopram—alcohol dependence	0.000535	0.000785	CcSEcCtD
Mesalazine—Chills—Citalopram—alcohol dependence	0.000533	0.000781	CcSEcCtD
Mesalazine—ALOX5—Metabolism—ADH6—alcohol dependence	0.000531	0.00528	CbGpPWpGaD
Mesalazine—Urticaria—Naltrexone—alcohol dependence	0.000529	0.000776	CcSEcCtD
Mesalazine—Body temperature increased—Naltrexone—alcohol dependence	0.000526	0.000772	CcSEcCtD
Mesalazine—Abdominal pain—Naltrexone—alcohol dependence	0.000526	0.000772	CcSEcCtD
Mesalazine—Alopecia—Citalopram—alcohol dependence	0.000525	0.000769	CcSEcCtD
Mesalazine—Mental disorder—Citalopram—alcohol dependence	0.00052	0.000763	CcSEcCtD
Mesalazine—Hypersensitivity—Acamprosate—alcohol dependence	0.000518	0.00076	CcSEcCtD
Mesalazine—CHUK—FoxO family signaling—EP300—alcohol dependence	0.000518	0.00515	CbGpPWpGaD
Mesalazine—Erythema—Citalopram—alcohol dependence	0.000517	0.000758	CcSEcCtD
Mesalazine—PPARG—Circadian rythm related genes—DRD4—alcohol dependence	0.000516	0.00513	CbGpPWpGaD
Mesalazine—Flatulence—Citalopram—alcohol dependence	0.000509	0.000747	CcSEcCtD
Mesalazine—Tension—Citalopram—alcohol dependence	0.000507	0.000744	CcSEcCtD
Mesalazine—Dysgeusia—Citalopram—alcohol dependence	0.000506	0.000742	CcSEcCtD
Mesalazine—Asthenia—Acamprosate—alcohol dependence	0.000505	0.00074	CcSEcCtD
Mesalazine—Nervousness—Citalopram—alcohol dependence	0.000502	0.000736	CcSEcCtD
Mesalazine—Back pain—Citalopram—alcohol dependence	0.0005	0.000733	CcSEcCtD
Mesalazine—PTGS1—Biological oxidations—ALDH2—alcohol dependence	0.000498	0.00496	CbGpPWpGaD
Mesalazine—Pruritus—Acamprosate—alcohol dependence	0.000498	0.00073	CcSEcCtD
Mesalazine—Muscle spasms—Citalopram—alcohol dependence	0.000497	0.000729	CcSEcCtD
Mesalazine—PTGS2—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000496	0.00494	CbGpPWpGaD
Mesalazine—Hypersensitivity—Naltrexone—alcohol dependence	0.00049	0.000719	CcSEcCtD
Mesalazine—Vision blurred—Citalopram—alcohol dependence	0.000487	0.000714	CcSEcCtD
Mesalazine—Tremor—Citalopram—alcohol dependence	0.000484	0.00071	CcSEcCtD
Mesalazine—Diarrhoea—Acamprosate—alcohol dependence	0.000481	0.000706	CcSEcCtD
Mesalazine—PPARG—Circadian rythm related genes—DRD2—alcohol dependence	0.000481	0.00478	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—HTR7—alcohol dependence	0.000481	0.00478	CbGpPWpGaD
Mesalazine—Ill-defined disorder—Citalopram—alcohol dependence	0.000479	0.000703	CcSEcCtD
Mesalazine—CHUK—IL-4 Signaling Pathway—EP300—alcohol dependence	0.000479	0.00477	CbGpPWpGaD
Mesalazine—CHUK—Validated transcriptional targets of TAp63 isoforms—EP300—alcohol dependence	0.000479	0.00477	CbGpPWpGaD
Mesalazine—Anaemia—Citalopram—alcohol dependence	0.000478	0.000701	CcSEcCtD
Mesalazine—Asthenia—Naltrexone—alcohol dependence	0.000478	0.000701	CcSEcCtD
Mesalazine—Angioedema—Citalopram—alcohol dependence	0.000472	0.000693	CcSEcCtD
Mesalazine—Pruritus—Naltrexone—alcohol dependence	0.000471	0.000691	CcSEcCtD
Mesalazine—IKBKB—FoxO family signaling—EP300—alcohol dependence	0.00047	0.00467	CbGpPWpGaD
Mesalazine—Malaise—Citalopram—alcohol dependence	0.000466	0.000684	CcSEcCtD
Mesalazine—Dizziness—Acamprosate—alcohol dependence	0.000465	0.000682	CcSEcCtD
Mesalazine—Vertigo—Citalopram—alcohol dependence	0.000464	0.000681	CcSEcCtD
Mesalazine—Syncope—Citalopram—alcohol dependence	0.000463	0.00068	CcSEcCtD
Mesalazine—Leukopenia—Citalopram—alcohol dependence	0.000463	0.000679	CcSEcCtD
Mesalazine—Palpitations—Citalopram—alcohol dependence	0.000457	0.00067	CcSEcCtD
Mesalazine—Diarrhoea—Naltrexone—alcohol dependence	0.000455	0.000668	CcSEcCtD
Mesalazine—Loss of consciousness—Citalopram—alcohol dependence	0.000454	0.000666	CcSEcCtD
Mesalazine—Cough—Citalopram—alcohol dependence	0.000451	0.000661	CcSEcCtD
Mesalazine—Vomiting—Acamprosate—alcohol dependence	0.000447	0.000656	CcSEcCtD
Mesalazine—Hypertension—Citalopram—alcohol dependence	0.000446	0.000654	CcSEcCtD
Mesalazine—Rash—Acamprosate—alcohol dependence	0.000444	0.000651	CcSEcCtD
Mesalazine—Dermatitis—Acamprosate—alcohol dependence	0.000443	0.00065	CcSEcCtD
Mesalazine—Headache—Acamprosate—alcohol dependence	0.000441	0.000647	CcSEcCtD
Mesalazine—Dizziness—Naltrexone—alcohol dependence	0.00044	0.000646	CcSEcCtD
Mesalazine—ALOX5—Metabolism—ADH1A—alcohol dependence	0.00044	0.00438	CbGpPWpGaD
Mesalazine—Chest pain—Citalopram—alcohol dependence	0.00044	0.000645	CcSEcCtD
Mesalazine—Arthralgia—Citalopram—alcohol dependence	0.00044	0.000645	CcSEcCtD
Mesalazine—Myalgia—Citalopram—alcohol dependence	0.00044	0.000645	CcSEcCtD
Mesalazine—Anxiety—Citalopram—alcohol dependence	0.000438	0.000643	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000437	0.000641	CcSEcCtD
Mesalazine—PPARG—Regulation of retinoblastoma protein—EP300—alcohol dependence	0.000435	0.00433	CbGpPWpGaD
Mesalazine—Discomfort—Citalopram—alcohol dependence	0.000435	0.000638	CcSEcCtD
Mesalazine—IKBKB—IL-4 Signaling Pathway—EP300—alcohol dependence	0.000435	0.00432	CbGpPWpGaD
Mesalazine—IKBKB—Validated transcriptional targets of TAp63 isoforms—EP300—alcohol dependence	0.000435	0.00432	CbGpPWpGaD
Mesalazine—Dry mouth—Citalopram—alcohol dependence	0.00043	0.000631	CcSEcCtD
Mesalazine—Confusional state—Citalopram—alcohol dependence	0.000425	0.000624	CcSEcCtD
Mesalazine—Vomiting—Naltrexone—alcohol dependence	0.000423	0.000621	CcSEcCtD
Mesalazine—Anaphylactic shock—Citalopram—alcohol dependence	0.000422	0.000619	CcSEcCtD
Mesalazine—Oedema—Citalopram—alcohol dependence	0.000422	0.000619	CcSEcCtD
Mesalazine—Rash—Naltrexone—alcohol dependence	0.00042	0.000616	CcSEcCtD
Mesalazine—Dermatitis—Naltrexone—alcohol dependence	0.000419	0.000615	CcSEcCtD
Mesalazine—Infection—Citalopram—alcohol dependence	0.000419	0.000615	CcSEcCtD
Mesalazine—CHUK—Validated nuclear estrogen receptor alpha network—EP300—alcohol dependence	0.000418	0.00416	CbGpPWpGaD
Mesalazine—Nausea—Acamprosate—alcohol dependence	0.000418	0.000613	CcSEcCtD
Mesalazine—Headache—Naltrexone—alcohol dependence	0.000417	0.000612	CcSEcCtD
Mesalazine—Shock—Citalopram—alcohol dependence	0.000415	0.000609	CcSEcCtD
Mesalazine—PPARG—Signaling events mediated by HDAC Class I—EP300—alcohol dependence	0.000415	0.00413	CbGpPWpGaD
Mesalazine—Nervous system disorder—Citalopram—alcohol dependence	0.000414	0.000607	CcSEcCtD
Mesalazine—Thrombocytopenia—Citalopram—alcohol dependence	0.000413	0.000606	CcSEcCtD
Mesalazine—Tachycardia—Citalopram—alcohol dependence	0.000412	0.000604	CcSEcCtD
Mesalazine—Skin disorder—Citalopram—alcohol dependence	0.00041	0.000601	CcSEcCtD
Mesalazine—CHUK—Cytosolic sensors of pathogen-associated DNA—EP300—alcohol dependence	0.000408	0.00406	CbGpPWpGaD
Mesalazine—Hyperhidrosis—Citalopram—alcohol dependence	0.000408	0.000598	CcSEcCtD
Mesalazine—PPARG—Circadian rythm related genes—AVP—alcohol dependence	0.000405	0.00403	CbGpPWpGaD
Mesalazine—Anorexia—Citalopram—alcohol dependence	0.000402	0.00059	CcSEcCtD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000402	0.004	CbGpPWpGaD
Mesalazine—PTGS1—Biological oxidations—CYP2E1—alcohol dependence	0.000398	0.00396	CbGpPWpGaD
Mesalazine—Nausea—Naltrexone—alcohol dependence	0.000395	0.00058	CcSEcCtD
Mesalazine—Hypotension—Citalopram—alcohol dependence	0.000394	0.000578	CcSEcCtD
Mesalazine—PPARG—Gene Expression—CCAR1—alcohol dependence	0.000393	0.00391	CbGpPWpGaD
Mesalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—alcohol dependence	0.000384	0.00382	CbGpPWpGaD
Mesalazine—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000384	0.000564	CcSEcCtD
Mesalazine—Insomnia—Citalopram—alcohol dependence	0.000381	0.00056	CcSEcCtD
Mesalazine—Paraesthesia—Citalopram—alcohol dependence	0.000379	0.000556	CcSEcCtD
Mesalazine—Dyspnoea—Citalopram—alcohol dependence	0.000376	0.000552	CcSEcCtD
Mesalazine—Somnolence—Citalopram—alcohol dependence	0.000375	0.00055	CcSEcCtD
Mesalazine—ALOX5—Metabolism—ADH4—alcohol dependence	0.000374	0.00372	CbGpPWpGaD
Mesalazine—Dyspepsia—Citalopram—alcohol dependence	0.000371	0.000545	CcSEcCtD
Mesalazine—IKBKB—Cytosolic sensors of pathogen-associated DNA—EP300—alcohol dependence	0.00037	0.00368	CbGpPWpGaD
Mesalazine—Decreased appetite—Citalopram—alcohol dependence	0.000367	0.000538	CcSEcCtD
Mesalazine—PTGS1—Biological oxidations—GGT1—alcohol dependence	0.000366	0.00364	CbGpPWpGaD
Mesalazine—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000364	0.000534	CcSEcCtD
Mesalazine—Fatigue—Citalopram—alcohol dependence	0.000364	0.000533	CcSEcCtD
Mesalazine—Pain—Citalopram—alcohol dependence	0.000361	0.000529	CcSEcCtD
Mesalazine—Constipation—Citalopram—alcohol dependence	0.000361	0.000529	CcSEcCtD
Mesalazine—CHUK—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—EP300—alcohol dependence	0.00035	0.00348	CbGpPWpGaD
Mesalazine—Feeling abnormal—Citalopram—alcohol dependence	0.000348	0.00051	CcSEcCtD
Mesalazine—Gastrointestinal pain—Citalopram—alcohol dependence	0.000345	0.000506	CcSEcCtD
Mesalazine—Urticaria—Citalopram—alcohol dependence	0.000335	0.000491	CcSEcCtD
Mesalazine—Body temperature increased—Citalopram—alcohol dependence	0.000333	0.000489	CcSEcCtD
Mesalazine—Abdominal pain—Citalopram—alcohol dependence	0.000333	0.000489	CcSEcCtD
Mesalazine—PPARG—Metabolism—ADH6—alcohol dependence	0.000329	0.00327	CbGpPWpGaD
Mesalazine—PTGS1—Biological oxidations—MAOA—alcohol dependence	0.000328	0.00326	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000324	0.00322	CbGpPWpGaD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000323	0.00321	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ADH7—alcohol dependence	0.000318	0.00317	CbGpPWpGaD
Mesalazine—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—EP300—alcohol dependence	0.000317	0.00316	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—WASF2—alcohol dependence	0.000311	0.0031	CbGpPWpGaD
Mesalazine—Hypersensitivity—Citalopram—alcohol dependence	0.000311	0.000456	CcSEcCtD
Mesalazine—ALOX5—Metabolism—GGT2—alcohol dependence	0.000305	0.00303	CbGpPWpGaD
Mesalazine—Asthenia—Citalopram—alcohol dependence	0.000303	0.000444	CcSEcCtD
Mesalazine—Pruritus—Citalopram—alcohol dependence	0.000298	0.000438	CcSEcCtD
Mesalazine—CHUK—Innate Immune System—WASF1—alcohol dependence	0.000298	0.00297	CbGpPWpGaD
Mesalazine—PPARG—PPARA activates gene expression—EP300—alcohol dependence	0.000289	0.00287	CbGpPWpGaD
Mesalazine—Diarrhoea—Citalopram—alcohol dependence	0.000289	0.000423	CcSEcCtD
Mesalazine—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—alcohol dependence	0.000283	0.00281	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—WASF2—alcohol dependence	0.000282	0.00281	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ADH1B—alcohol dependence	0.000279	0.00278	CbGpPWpGaD
Mesalazine—Dizziness—Citalopram—alcohol dependence	0.000279	0.000409	CcSEcCtD
Mesalazine—PPARG—Metabolism—ADH1A—alcohol dependence	0.000272	0.00271	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—WASF1—alcohol dependence	0.00027	0.00269	CbGpPWpGaD
Mesalazine—Vomiting—Citalopram—alcohol dependence	0.000268	0.000393	CcSEcCtD
Mesalazine—Rash—Citalopram—alcohol dependence	0.000266	0.00039	CcSEcCtD
Mesalazine—Dermatitis—Citalopram—alcohol dependence	0.000266	0.00039	CcSEcCtD
Mesalazine—Headache—Citalopram—alcohol dependence	0.000264	0.000388	CcSEcCtD
Mesalazine—Nausea—Citalopram—alcohol dependence	0.000251	0.000367	CcSEcCtD
Mesalazine—PPARG—Developmental Biology—GRIN2B—alcohol dependence	0.000242	0.00241	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ADH4—alcohol dependence	0.000232	0.0023	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—MAOB—alcohol dependence	0.000231	0.0023	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ADH6—alcohol dependence	0.00023	0.00229	CbGpPWpGaD
Mesalazine—PTGS1—Biological oxidations—POMC—alcohol dependence	0.000213	0.00212	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000211	0.00209	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000201	0.00199	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—EP300—alcohol dependence	0.000199	0.00198	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ADH7—alcohol dependence	0.000197	0.00196	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ALDH2—alcohol dependence	0.000197	0.00196	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—OPRK1—alcohol dependence	0.000196	0.00195	CbGpPWpGaD
Mesalazine—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	0.000195	0.00194	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ADH1A—alcohol dependence	0.000191	0.0019	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000189	0.00188	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GGT2—alcohol dependence	0.000189	0.00188	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ADH6—alcohol dependence	0.000183	0.00182	CbGpPWpGaD
Mesalazine—CHUK—Immune System—WASF2—alcohol dependence	0.000181	0.0018	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—EP300—alcohol dependence	0.000178	0.00177	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—OPRK1—alcohol dependence	0.000177	0.00176	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000174	0.00174	CbGpPWpGaD
Mesalazine—CHUK—Immune System—WASF1—alcohol dependence	0.000174	0.00173	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ADH1B—alcohol dependence	0.000173	0.00172	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GOT2—alcohol dependence	0.000167	0.00166	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—WASF2—alcohol dependence	0.000164	0.00163	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ADH4—alcohol dependence	0.000162	0.00161	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—WASF1—alcohol dependence	0.000158	0.00157	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CYP2E1—alcohol dependence	0.000157	0.00156	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ADH1A—alcohol dependence	0.000151	0.00151	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GOT1—alcohol dependence	0.000144	0.00144	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GGT1—alcohol dependence	0.000144	0.00144	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—MAOB—alcohol dependence	0.000143	0.00142	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.00014	0.0014	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ADH7—alcohol dependence	0.000138	0.00137	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GGT2—alcohol dependence	0.000132	0.00132	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—OPRD1—alcohol dependence	0.000131	0.00131	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—MAOA—alcohol dependence	0.000129	0.00129	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ADH4—alcohol dependence	0.000129	0.00128	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PDYN—alcohol dependence	0.000126	0.00125	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000125	0.00125	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALDH2—alcohol dependence	0.000122	0.00121	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ADH1B—alcohol dependence	0.000121	0.0012	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—OPRD1—alcohol dependence	0.000119	0.00119	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CRHR1—alcohol dependence	0.000117	0.00117	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—WASF2—alcohol dependence	0.000117	0.00117	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000117	0.00116	CbGpPWpGaD
Mesalazine—CHUK—Disease—GOT2—alcohol dependence	0.000116	0.00115	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PDYN—alcohol dependence	0.000114	0.00114	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—WASF1—alcohol dependence	0.000112	0.00112	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000112	0.00111	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CHRM2—alcohol dependence	0.00011	0.0011	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ADH7—alcohol dependence	0.00011	0.00109	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CRHR1—alcohol dependence	0.000106	0.00106	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—WASF2—alcohol dependence	0.000106	0.00106	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GGT2—alcohol dependence	0.000105	0.00104	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GOT2—alcohol dependence	0.000103	0.00103	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000103	0.00103	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—WASF1—alcohol dependence	0.000102	0.00101	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—OPRM1—alcohol dependence	0.000101	0.00101	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—MAOB—alcohol dependence	0.0001	0.000997	CbGpPWpGaD
Mesalazine—CHUK—Disease—GOT1—alcohol dependence	0.0001	0.000996	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CHRM2—alcohol dependence	9.99e-05	0.000994	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CYP2E1—alcohol dependence	9.73e-05	0.000968	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ADH1B—alcohol dependence	9.6e-05	0.000955	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NPY—alcohol dependence	9.31e-05	0.000926	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—OPRM1—alcohol dependence	9.17e-05	0.000912	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CRH—alcohol dependence	8.98e-05	0.000893	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR1B—alcohol dependence	8.98e-05	0.000893	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GOT1—alcohol dependence	8.93e-05	0.000888	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GGT1—alcohol dependence	8.93e-05	0.000888	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—EP300—alcohol dependence	8.69e-05	0.000865	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALDH2—alcohol dependence	8.52e-05	0.000848	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NPY—alcohol dependence	8.44e-05	0.00084	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—POMC—alcohol dependence	8.42e-05	0.000837	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	8.2e-05	0.000815	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CRH—alcohol dependence	8.14e-05	0.00081	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR1B—alcohol dependence	8.14e-05	0.00081	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—MAOA—alcohol dependence	8e-05	0.000796	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MAOB—alcohol dependence	7.96e-05	0.000792	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—DRD4—alcohol dependence	7.85e-05	0.000781	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	7.76e-05	0.000772	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CNR1—alcohol dependence	7.49e-05	0.000746	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR7—alcohol dependence	7.31e-05	0.000727	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—DRD2—alcohol dependence	7.31e-05	0.000727	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GOT2—alcohol dependence	7.25e-05	0.000721	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—EP300—alcohol dependence	7.2e-05	0.000717	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—DRD4—alcohol dependence	7.12e-05	0.000708	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GOT2—alcohol dependence	6.87e-05	0.000683	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYP2E1—alcohol dependence	6.81e-05	0.000678	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CNR1—alcohol dependence	6.8e-05	0.000676	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALDH2—alcohol dependence	6.77e-05	0.000673	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—DRD2—alcohol dependence	6.63e-05	0.00066	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR7—alcohol dependence	6.63e-05	0.00066	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—EP300—alcohol dependence	6.53e-05	0.00065	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	6.51e-05	0.000647	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GOT1—alcohol dependence	6.26e-05	0.000622	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GGT1—alcohol dependence	6.26e-05	0.000622	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—AVP—alcohol dependence	6.15e-05	0.000612	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GOT1—alcohol dependence	5.93e-05	0.00059	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GOT2—alcohol dependence	5.75e-05	0.000572	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—MAOA—alcohol dependence	5.61e-05	0.000558	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—EP300—alcohol dependence	5.58e-05	0.000555	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—AVP—alcohol dependence	5.58e-05	0.000555	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	5.44e-05	0.000541	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP2E1—alcohol dependence	5.41e-05	0.000538	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—POMC—alcohol dependence	5.21e-05	0.000518	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HTR2A—alcohol dependence	5.12e-05	0.000509	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GGT1—alcohol dependence	4.97e-05	0.000494	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GOT1—alcohol dependence	4.97e-05	0.000494	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HTR2A—alcohol dependence	4.64e-05	0.000462	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—MAOA—alcohol dependence	4.45e-05	0.000443	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	4.32e-05	0.000429	CbGpPWpGaD
Mesalazine—CHUK—Immune System—EP300—alcohol dependence	4.2e-05	0.000417	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—POMC—alcohol dependence	4.09e-05	0.000407	CbGpPWpGaD
Mesalazine—CHUK—Disease—EP300—alcohol dependence	3.87e-05	0.000385	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—EP300—alcohol dependence	3.81e-05	0.000379	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—POMC—alcohol dependence	3.71e-05	0.000369	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—POMC—alcohol dependence	3.65e-05	0.000363	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—EP300—alcohol dependence	3.46e-05	0.000344	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—POMC—alcohol dependence	2.9e-05	0.000288	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EP300—alcohol dependence	2.71e-05	0.00027	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EP300—alcohol dependence	2.46e-05	0.000245	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—EP300—alcohol dependence	2.42e-05	0.000241	CbGpPWpGaD
Mesalazine—PTGS2—Disease—EP300—alcohol dependence	2.29e-05	0.000228	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—EP300—alcohol dependence	1.92e-05	0.000191	CbGpPWpGaD
